Abbott Laboratories (ABT) EPS: History & Chart

Abbott Laboratories (ABT)ABTAbbott Laboratories

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

114,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

ABT Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

3.11

EARNINGS PER SHARE (EPS) AVG TTM

5.71

EARNINGS PER SHARE (EPS) AVG 3Y

4.66

EARNINGS PER SHARE (EPS) AVG 5Y

4.19

EARNINGS PER SHARE (EPS) AVG 10Y

2.98

EARNINGS PER SHARE (EPS) AVG 15Y

2.54

EARNINGS PER SHARE (EPS) AVG 20Y

2.53

CURRENT VS TTM AVG

-45.49%

CURRENT VS 3Y AVG

-33.30%

CURRENT VS 5Y AVG

-25.78%

CURRENT VS 10Y AVG

+4.36%

CURRENT VS 15Y AVG

+22.57%

CURRENT VS 20Y AVG

+23.00%

NAME	MARKET CAP	EARNINGS PER SHARE (EPS)	TTM	3Y	5Y
Abbott Laboratories (ABT)	$179.58B	3.11	5.71	4.66	4.19
Gilead Sciences, Inc. (GILD)vs ›	$160.55B	7.34	3.61	3.85	3.41
Amgen Inc. (AMGN)vs ›	$202.95B	14.37	10.97	11.67	11.57
Thermo Fisher Scientific Inc. (TMO)vs ›	$211.18B	18.59	17.17	16.90	17.22
Novo Nordisk A/S (NVO)vs ›	$216.72B	4.27	3.38	2.82	2.39
Pfizer Inc. (PFE)vs ›	$139.86B	1.31	1.39	2.19	2.39
CVS Health Corp. (CVS)vs ›	$137.47B	2.27	2.53	3.71	4.39
Danaher Corporation (DHR)vs ›	$134.62B	5.63	5.20	6.66	6.73
Bristol-Myers Squibb Company (BMY)vs ›	$126.79B	3.56	-0.48	1.47	0.84
Stryker Corporation (SYK)vs ›	$126.60B	8.64	8.18	7.73	6.75

NAME

MARKET CAP

EARNINGS PER SHARE (EPS)

TTM

Abbott Laboratories (ABT)

$179.58B

3.11

5.71

4.66

4.19

Gilead Sciences, Inc. (GILD)vs ›

$160.55B

7.34

3.61

3.85

3.41

Amgen Inc. (AMGN)vs ›

$202.95B

14.37

10.97

11.67

11.57

Thermo Fisher Scientific Inc. (TMO)vs ›

$211.18B

18.59

17.17

16.90

17.22

Novo Nordisk A/S (NVO)vs ›

$216.72B

4.27

3.38

2.82

2.39

Pfizer Inc. (PFE)vs ›

$139.86B

1.31

1.39

2.19

2.39

CVS Health Corp. (CVS)vs ›

$137.47B

2.27

2.53

3.71

4.39

Danaher Corporation (DHR)vs ›

$134.62B

5.63

5.20

6.66

6.73

Bristol-Myers Squibb Company (BMY)vs ›

$126.79B

3.56

-0.48

1.47

0.84

Stryker Corporation (SYK)vs ›

$126.60B

8.64

8.18

7.73

6.75

Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Abbott Laboratories (ABT)?

The earnings per share (EPS) for ABT stock is 3.11.

Is Abbott Laboratories's earnings per share (EPS) high or low?

The earnings per share (EPS) of 3.11 is 26% below its 5-year average of 4.19, near the low end of its 5-year range (2.52–7.67).

What is the TTM average earnings per share (EPS) for Abbott Laboratories (ABT)?

The TTM average earnings per share (EPS) for ABT stock is 5.71.

What is the 3Y average earnings per share (EPS) for Abbott Laboratories (ABT)?

The 3Y average earnings per share (EPS) for ABT stock is 4.66.

What is the 5Y average earnings per share (EPS) for Abbott Laboratories (ABT)?

The 5Y average earnings per share (EPS) for ABT stock is 4.19.

What is the 10Y average earnings per share (EPS) for Abbott Laboratories (ABT)?

The 10Y average earnings per share (EPS) for ABT stock is 2.98.

What is the 15Y average earnings per share (EPS) for Abbott Laboratories (ABT)?

The 15Y average earnings per share (EPS) for ABT stock is 2.54.

What is the 20Y average earnings per share (EPS) for Abbott Laboratories (ABT)?

The 20Y average earnings per share (EPS) for ABT stock is 2.53.

DATE	EARNINGS PER SHARE (EPS)
2025-12-31	3.74
2024-12-31	7.67
2023-12-31	3.30
2022-12-31	3.94
2021-12-31	3.97
2020-12-31	2.52
2019-12-31	2.07
2018-12-31	1.35
2017-12-31	0.27
2016-12-31	0.95
2015-12-31	3.00
2014-12-31	1.51
2013-12-31	1.66
2012-12-31	3.78
2011-12-31	3.01
2010-12-31	2.99
2009-12-31	3.72
2008-12-31	3.16
2007-12-31	2.34
2006-12-31	1.12
2005-12-31	2.17
2004-12-31	2.07
2003-12-31	1.76
2002-12-31	1.79
2001-12-31	1.00
2000-12-31	1.80
1999-12-31	1.59
1998-12-31	1.52
1997-12-31	1.35
1996-12-31	1.21

DATE

EARNINGS PER SHARE (EPS)

2025-12-31

3.74

2024-12-31

7.67

2023-12-31

3.30

2022-12-31

3.94

2021-12-31

3.97

2020-12-31

2.52

2019-12-31

2.07

2018-12-31

1.35

2017-12-31

0.27

2016-12-31

0.95

2015-12-31

3.00

2014-12-31

1.51

2013-12-31

1.66

2012-12-31

3.78

2011-12-31

3.01

2010-12-31

2.99

2009-12-31

3.72

2008-12-31

3.16

2007-12-31

2.34

2006-12-31

1.12

2005-12-31

2.17

2004-12-31

2.07

2003-12-31

1.76

2002-12-31

1.79

2001-12-31

1.00

2000-12-31

1.80

1999-12-31

1.59

1998-12-31

1.52

1997-12-31

1.35

1996-12-31

1.21

Earnings Per Share (EPS): 3.11

ABT Earnings Per Share (EPS)

ABT Quarterly EPS Growth (YoY)

ABT Average Earnings Per Share (EPS) Chart

ABT Current vs Average Earnings Per Share (EPS) Chart

ABT Earnings Per Share (EPS) Metrics

ABT Competitors' Earnings Per Share (EPS)

EPS Comparison

Earnings Per Share (EPS) Formula & Definition

Earnings Per Share (EPS) FAQ

ABT Earnings Per Share (EPS) History

Related Metrics